Strumento inattivo

Altre lingue Luckwel Pharmaceuticals Inc. Other OTC

Azioni

LWEL

US54959L1017

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	01/10/21
LUCKWEL PHARMACEUTICALS : Changes in Registrant's Certifying Accountant, Non-Reliance on Previous Financials, Audits or Interim Review, Financial Statements and Exhibits (form 8-K/A)	22/09/21
LUCKWEL PHARMACEUTICALS INC. : Changes in Registrant's Certifying Accountant, Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	21/09/21
LUCKWEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	09/09/21
LUCKWEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	07/09/21
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020	07/09/21
LUCKWEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	10/06/21
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended March 31, 2020	10/06/21
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	26/05/21
Luckwel Pharmaceuticals Inc. announced that it expects to receive $0.075 million in funding from Bounty Company Limited	14/05/21
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	27/04/21
Luckwel Pharmaceuticals Inc. announced that it expects to receive $0.12 million in funding	20/04/21
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement (form 8-K)	22/03/21
LUCKWEL PHARMACEUTICALS INC. : Unregistered Sale of Equity Securities (form 8-K)	12/02/21
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement (form 8-K)	05/02/21
LUCKWEL PHARMACEUTICALS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	19/01/21
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	13/01/21
LUCKWEL PHARMACEUTICALS INC. : Other Events (form 8-K)	04/01/21
Luckwel Pharmaceuticals Inc. Announces Address Changes	04/01/21
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019	13/02/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Luckwel Pharmaceuticals Inc. Other OTC

Azioni

LWEL

US54959L1017

Altre lingue

Filtri